Data Characteristics in This Domain
Data in the rational drug use and pharmacovigilance domain primarily originates from drug inserts, clinical guidelines, adverse drug reaction (ADR) reports, pharmaceutical literature, and various drug databases. Update frequencies vary: drug inserts and clinical guidelines typically update annually or upon new drug approvals, while ADR reports generate continuously in real-time. Document structures differ; drug inserts are semi-structured text with fixed sections like indications, dosage and administration, contraindications, and adverse reactions. Pharmaceutical literature is mostly unstructured text, appearing as research papers. ADR reports are usually structured, containing fields for patient information, drug information, ADR description, and severity. Specificity in fields and units includes dosage units (e.g., mg, g, IU), frequency (e.g., once daily, hourly), and standardized medical terminology for ADR descriptions (e.g., MedDRA coding).
Constraints Imposed by These Characteristics on Reference and Traceability
Data characteristics in rational drug use impose specific requirements on reference and traceability. The semi-structured nature of drug inserts and clinical guidelines necessitates precise referencing to specific sections or paragraphs, such as the "Dosage and Administration" section. Structured ADR report data requires traceability to specific report IDs and relevant fields. Diverse data sources with varying update frequencies demand that the knowledge base handles multiple document formats during ingestion and indexing, and records the latest update time for each source. Standardized medical terminology requires the knowledge base to identify and associate similar concepts expressed differently during semantic understanding and matching, ensuring traceability accuracy (e.g., linking "nausea and vomiting" to its corresponding MedDRA code). Unstructured pharmaceutical literature requires more robust text segmentation and summarization capabilities to provide concise and accurate context for referencing.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Segment Length) | 500–800 characters | Ensures each segment contains sufficient contextual information while avoiding excessive length that could disperse meaning, facilitating precise referencing of specific paragraphs in drug inserts. |
Recall count (Recall Count) | 8–12 items | Considering the complexity of rational drug use, recalling a sufficient number of relevant document fragments is necessary to cover potential associated information, such as drug interactions. |
Similarity threshold (Similarity Threshold) | 0.75–0.85 | Guarantees high relevance between recalled results and query intent, preventing the introduction of irrelevant pharmaceutical knowledge or ADR reports, thereby improving traceability accuracy. |
Rerank result count (Reranked Return Count) | 3–5 items | Reranks initial recall results to select the most relevant fragments as final reference sources, highlighting key pharmacovigilance information. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Addresses the parsing requirements for large clinical guidelines or complex drug inserts, ensuring complete file processing without interruption. |
maxContext | 3000 Tokens | Provides the model with a sufficient context window to understand the nuances of pharmacovigilance queries and synthesize accurate references from recalled fragments. |
Common Pitfalls
- Reference links returned by the model are broken: This typically occurs when the original knowledge base file is moved or deleted after upload, invalidating the storage path.
- When asked about adverse drug reactions, the model fails to cite specific report numbers: This may be due to incorrect ingestion configuration in the knowledge base that did not properly identify the
Report IDfield in ADR reports, or critical information was split during segmentation. - When querying for contraindications of a drug, the returned reference sources are about side effects: This indicates that the semantic matching or reranking stage did not sufficiently differentiate between drug contraindications and adverse reactions, which are distinct medical concepts.
Validation Steps
- For typical pharmacovigilance scenarios (e.g., "hepatic toxicity manifestations of a certain drug"), verify that the reference sources returned by the model accurately point to the "Adverse Reactions" section of the relevant drug insert or specific paragraphs in clinical guidelines.
- Submit rational drug use queries containing specific drugs, dosages, and patient characteristics. Check if the cited pharmaceutical literature covers these key details and if the reference links are accessible.
- Input queries about drug interactions. Verify that the cited knowledge base fragments clearly indicate the type, mechanism, and recommended avoidance measures for interactions, and can be traced back to the original drug database or literature.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.